Top Markets
#1 Black Phoenix Black Phoenix +17,837.96%
#2 Cash Dog in Hood Cash Dog in Hood +6,493.59%
#3 AgentFun.AI AgentFun.AI +54.83%
#4 up up +49.01%
#5 Arrow Arrow +48.53%
#6 Quai Network Quai Network +39.70%
#7 Octra Octra +37.04%
#8 Derive Derive +34.20%
#9 Block Street Block Street +31.33%
#10 B3 (Base) B3 (Base) +31.22%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Theranexus Société Anonyme Theranexus Société Anonyme

Theranexus Société Anonyme

ALTHX
Rank in Stocks #15061
Theranexus société anonyme, a biopharmaceutical company, develops drug... Theranexus société anonyme, a biopharmaceutical company, develops drug candidates for the treatment of central nervous system disorders. The company's lead drug candidate is THN102, which is in Phase II clinical trial to treat sleep/wake disorders. It also develops THN201 for the treatment of neurocognitive disorders linked to Alzheimer's disease; and THN101 to treat neuropathic pain. The company was founded in 2013 and is based in Lyon, France.
Share Price
$4.66
Market Cap
$43.92M
Change (1 day)
-0.63%
Change (1 year)
338.04%
Country
FR
Trade Theranexus Société Anonyme (ALTHX)

Category

Healthcare
Number of shares outstanding for Theranexus Société Anonyme (ALTHX)
Number of shares outstanding as of December 2025: 13.76M
According to Theranexus Société Anonyme latest financial reports and stock price the company's current number of shares outstanding is 13.76M. At the end of December 2023 the company had 7.76M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Theranexus Société Anonyme (ALTHX) from 2015 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
2026 (TTM) 13.76M 61.18%
2024 8.54M 10.03%
2023 7.76M 45.98%
2022 5.32M 7.95%
2021 4.92M 21.15%
2020 4.06M 13.16%
2019 3.59M 15.14%
2018 3.12M 0.00%
2017 3.12M 250.90%
2016 888.89K 0.00%
2015 888.89K 0.00%
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 4.44B 32,187.30%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 254.10M 1,746.74%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 104.00M 655.85%
US
UCB SA UCB SA
UCB SA
UCB.BR
 190.00M 1,280.85%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 61.42M 346.38%
NL